Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
Neutralizing antibody levels rose 37-fold one month after the booster was given. Moderna announced Monday that its COVID-19 vaccine booster increases antibody levels against the omicron variant within ...
WOBURN, Mass., July 10, 2023 /PRNewswire/ -- Ultrasensitive immunoassays developer Spear Bio is expanding its family of NAB-Sure™ SARS Cov-2 Neutralizing Antibodies test kits. Previously released kits ...
(Reuters) - LabCorp said on Thursday it has launched a new test that could assess the capacity of antibodies in patient plasma to inhibit the novel coronavirus. Information from the test about the ...
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare solutions company, announced today their ...
Llama antibodies clamp the coronavirus shut at its weakest spot—leaving the virus powerless to mutate or infect.
SAN DIEGO, July 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched ...
Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons. Usually, clinical trials are paused because a volunteer has suffered a ...
Invivyd Inc (NASDAQ:IVVD) shares are trading higher after the company released initial results from the ongoing CANOPY Phase 3 pivotal clinical trial of VYD222, a broadly neutralizing, half-life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results